Endophytic microbial platforms for sustainable production of plant-derived anticancer metabolites

Cancer continues to pose a major global health challenge, with increasing incidence and mortality worldwide. Although modern cancer therapies have advanced significantly, many clinically important anticancer drugs still originate from plant-derived secondary metabolites due to their structural diversity and potent bioactivity. Compounds such as Podophyllotoxin, Paclitaxel, Vincristine, and Camptothecin have transformed cancer treatment and serve as precursors for several clinically used therapeutics. However, their production relies largely on extraction from slow-growing and often overexploited medicinal plants such as Podophyllum hexandrum , Taxus brevifolia , Catharanthus roseus , and Camptotheca acuminata , making supply environmentally and economically unsustainable. Endophytic microorganisms have emerged as promising alternative biofactories for sustainable production of these high-value metabolites. Several fungal and bacterial endophytes, including species of Fusarium , Alternaria , Chaetomium , and Taxomyces andreanae , have been reported to produce anticancer compounds or stimulate their biosynthesis in host plants. Recent advances in synthetic biology, metabolic engineering, CRISPR-based genome editing, heterologous expression in microbial hosts, elicitor-assisted cultivation, and bioreactor-based fermentation have significantly improved metabolite yields and scalability. This review highlights recent progress in identifying endophytic producers, optimizing biosynthetic pathways, and developing industrially viable microbial platforms for sustainable production of plant-derived anticancer metabolites.

Authors

Institutions

Publication Details

Journal
Discover Life
Published
2026-11-21
DOI
https://doi.org/10.1007/s11084-026-09775-z
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Endophytic microbial platforms for sustainable production of plant-derived anticancer metabolites

Shiv Shanker Pandey, Manju Kumari, Alok Kalra, Rajesh Verma et al.
Discover Life
Microbial Natural Products and Biosynthesis
article

Endophytic microbial platforms for sustainable production of plant-derived anticancer metabolites

Shiv Shanker Pandey, Manju Kumari, Alok Kalra, Rajesh Verma, Nikhil Rawat, Shivam Singh Chauhan, Riya Jaiswal
article en

Abstract

Cancer continues to pose a major global health challenge, with increasing incidence and mortality worldwide. Although modern cancer therapies have advanced significantly, many clinically important anticancer drugs still originate from plant-derived secondary metabolites due to their structural diversity and potent bioactivity. Compounds such as Podophyllotoxin, Paclitaxel, Vincristine, and Camptothecin have transformed cancer treatment and serve as precursors for several clinically used therapeutics. However, their production relies largely on extraction from slow-growing and often overexploited medicinal plants such as Podophyllum hexandrum , Taxus brevifolia , Catharanthus roseus , and Camptotheca acuminata , making supply environmentally and economically unsustainable. Endophytic microorganisms have emerged as promising alternative biofactories for sustainable production of these high-value metabolites. Several fungal and bacterial endophytes, including species of Fusarium , Alternaria , Chaetomium , and Taxomyces andreanae , have been reported to produce anticancer compounds or stimulate their biosynthesis in host plants. Recent advances in synthetic biology, metabolic engineering, CRISPR-based genome editing, heterologous expression in microbial hosts, elicitor-assisted cultivation, and bioreactor-based fermentation have significantly improved metabolite yields and scalability. This review highlights recent progress in identifying endophytic producers, optimizing biosynthetic pathways, and developing industrially viable microbial platforms for sustainable production of plant-derived anticancer metabolites.

Discover LifeVol. 56(1)
Institute of Himalayan Bioresource Technology (IN), Central Institute of Medicinal and Aromatic Plants (IN), Academy of Scientific and Innovative Research (IN)
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon